Restrictions on obesity drug coverage force patients to pivot
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
Original Source
Read the full article at Npr →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.